Picked up $Axogen(AXGN.US) on VWAP reclaim after gap-fill back to $40 on strong earnings that got sold off due to stock being too extended. AI notes below. NFA
Axogen (AXGN)
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and re...
- Open
- 51.310
- High
- 52.910
- Low
- 51.160
- Prev. Close
- 51.580
- Volume
- 627.23K
- Turnover
- 32.71M
- Avg Price
- 52.156
- Bid/Ask Ratio
- -97.97%
- Amplitude
- 3.39%
- 52wk High
- 52.910
- Volume Ratio
- 0.66
- Turnover Ratio
- 1.19%
Axogen Analyst Rating
View moreForecast & Rating
Aug 26, 2026Price forecast
$53.903.65%
Forecast & RatingStrong buy
10analysts
- Strong buy80.00%
- Buy20.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Simplywall · Aug 24 at 12:17 AM
Is Axogen (AXGN) Still Undervalued After Its Sharp Rally?
- PUBT · Aug 11 at 03:18 PM
Axogen director Kathy Johnson Weiler disposes of common shares worth $640.948,70
- Global Report · Aug 11 at 04:43 AM
The Invisible AI Bottleneck: How Advanced Testing and Space Tech Are Redefining Hardware
- Simplywall · Aug 2 at 06:31 PM
Why Axogen (AXGN) Is Up 6.9% After Raising 2026 Revenue Guidance Despite First-Half Loss
- Market Beat · Aug 2 at 02:05 AM
Arrowstreet Capital Limited Partnership Lowers Stock Holdings in AxoGen, Inc. $AXGN
- Simplywall · Aug 1 at 10:12 AM
Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter Report